Boomfish Wealth Group’s Boston Scientific BSX Stock Holding History

Boomfish Wealth Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,350	Closed	-$327K	–	86
2025 Q3	$327K	Hold	3,350	–	–	0.18%	77
2025 Q2	$360K	Hold	3,350	–	–	0.21%	75
2025 Q1	$338K	Hold	3,350	–	–	0.22%	71
2024 Q4	$299K	Hold	3,350	–	–	0.18%	80
2024 Q3	$281K	Buy	+3,350	New	+$264K	0.17%	82

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Boomfish Wealth Group's BSX Position: Q4 2025 in Review

Boomfish Wealth Group sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 3,350 shares — an estimated $327K sold.

Boomfish Wealth Group first reported a position in BSX in Q3 2024 and held it in 5 quarters. The position peaked at $360K in Q2 2025. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Boomfish Wealth Group reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Boomfish Wealth Group sold 3,350 Boston Scientific shares in Q4 2025, an estimated $327K.
Boomfish Wealth Group first reported a position in Boston Scientific in Q3 2024 and held it in 5 quarters.
Boomfish Wealth Group's Boston Scientific position peaked at $360K in Q2 2025.
1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Boomfish Wealth Group's 13F filing for Q4 2025, filed 21 Jan 2026.